DFMO: an alternative therapeutic agent for human African trypanosomiasis

Breton, J.C.; Bouteille, B.; Sonan, T.

Bulletin de la Societe de Pathologie Exotique et de Ses Filiales 81(3 Part 2): 571-577

1988


ISSN/ISBN: 0037-9085
PMID: 3143490
Document Number: 321812
alpha-Difluoromethyl ornithine (DFMO) irreversibly inhibits ornithine decarboxylase (ODC), an essential enzyme for the synthesis of polyamines, and results in decreased biosynthesis of putrescine and spermidine, factors necessary for cellular multiplication. Use of this chemical agent in Trypanosoma brucei brucei infected mice eradicated the parasite from circulating blood. This treatment is now being developed for use in human pathology.

Document emailed within 1 workday
Secure & encrypted payments